These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31345843)

  • 1. Managing All the Genotypic Knowledge: Approach to a Septic Patient Colonized by Different
    Park SC; Wailan AM; Barry KE; Vegesana K; Carroll J; Mathers AJ; Miller WR; Munita JM
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31345843
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kazmierczak KM; Bradford PA; Stone GG; de Jonge BLM; Sahm DF
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249690
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
    Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
    Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization of intestinal microbiota with carbapenemase-producing Enterobacteriaceae in paediatric intensive care units in Cairo, Egypt.
    Ghaith DM; Mohamed ZK; Farahat MG; Aboulkasem Shahin W; Mohamed HO
    Arab J Gastroenterol; 2019 Mar; 20(1):19-22. PubMed ID: 30733176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
    Balkan II; Aygün G; Aydın S; Mutcalı SI; Kara Z; Kuşkucu M; Midilli K; Şemen V; Aras S; Yemişen M; Mete B; Özaras R; Saltoğlu N; Tabak F; Öztürk R
    Int J Infect Dis; 2014 Sep; 26():51-6. PubMed ID: 24998423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare cause of infection, Raoultella planticola: emerging threat and new reservoir for carbapenem resistance.
    Demiray T; Koroglu M; Ozbek A; Altindis M
    Infection; 2016 Dec; 44(6):713-717. PubMed ID: 27147419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Report of Klebsiella oxytoca Strain Simultaneously Producing NDM-1, IMP-4, and KPC-2 Carbapenemases.
    Wang J; Yuan M; Chen H; Chen X; Jia Y; Zhu X; Bai L; Bai X; Fanning S; Lu J; Li J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28674063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.
    Jeong SH; Kim HS; Kim JS; Shin DH; Kim HS; Park MJ; Shin S; Hong JS; Lee SS; Song W
    Ann Lab Med; 2016 Nov; 36(6):529-35. PubMed ID: 27578505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital.
    Aquino-Andrade A; Merida-Vieyra J; Arias de la Garza E; Arzate-Barbosa P; De Colsa Ranero A
    BMC Microbiol; 2018 Apr; 18(1):38. PubMed ID: 29673319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by
    Guimarães T; Nouér SA; Martins RCR; Perdigão Neto LV; Martins WMBS; Narciso Barbosa AC; Ferreira ALP; Costa SF; Gales AC
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteremia with Carbapenemase-Producing
    Averbuch D; Moshkovitz L; Ilan S; Abu Ahmad W; Temper V; Strahilevitz J
    Microb Drug Resist; 2022 May; 28(5):593-600. PubMed ID: 35580283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients.
    Castón JJ; Lacort-Peralta I; Martín-Dávila P; Loeches B; Tabares S; Temkin L; Torre-Cisneros J; Paño-Pardo JR
    Int J Infect Dis; 2017 Jun; 59():118-123. PubMed ID: 28392315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.
    Saïdani M; Hammami S; Kammoun A; Slim A; Boutiba-Ben Boubaker I
    J Med Microbiol; 2012 Dec; 61(Pt 12):1746-1749. PubMed ID: 22918869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
    Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
    J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in-house and commercial real time-PCR based carbapenemase gene detection methods in Enterobacteriaceae and non-fermenting gram-negative bacterial isolates.
    Smiljanic M; Kaase M; Ahmad-Nejad P; Ghebremedhin B
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):48. PubMed ID: 28693493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam.
    De la Calle C; Rodríguez O; Morata L; Marco F; Cardozo C; García-Vidal C; Río AD; Feher C; Pellicé M; Puerta-Alcalde P; Mensa J; Soriano A; Martínez JA
    Int J Antimicrob Agents; 2019 Apr; 53(4):520-524. PubMed ID: 30471403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.